Seltene erkrankungen seltene erkrankungen betreffen nur wenige patienten und sind oft lebensbedrohlich oder verursachen chronische behinderungen. insgesamt gibt es ungefähr 7.000 bekannte seltene erkrankungen, aber nur etwa 400 zugelassene therapien. mehr erfahren. About us sobi is a specialised international biopharmaceutical company transforming the lives of people with rare and debilitating diseases. inspired by caring, powered by science, we are dedicated to: ensuring every eligible person living with a rare and debilitating disease within our disease areas is given the opportunity to benefit from our approved medicines delivering innovative.
Our science | r&d innovative medicines in the pipeline only 5 % of rare diseases have approved medicines. the need for innovative treatments is, therefore, high. a strong pipeline and expanded access are key elements of our commitment to patients. view pipeline investor relations q2 report sobi published its report on 16 july. report presentation audiocast invitation aide memoire report. Sobi is an international specialty healthcare company dedicated to rare diseases with a focus on treatments in haematology, immunology and speciality care. [2] in 2013, sobi had total revenues of sek 2.2 billion (€253 m) and about 550 employees; [ 9 ] by 2020 the revenue was sek 15.261 billion and there were 1,509 employees. [ 2 ]. Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare diseases. we provide sustainable access to innovative therapies in the areas of haematology. Share this article. stockholm, june 2, 2023 prnewswire sobi ® will present data at the eha (european haematology association) hybrid congress taking place in frankfurt, germany 8 11 june.
Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare diseases. we provide sustainable access to innovative therapies in the areas of haematology. Share this article. stockholm, june 2, 2023 prnewswire sobi ® will present data at the eha (european haematology association) hybrid congress taking place in frankfurt, germany 8 11 june. Sobi is a specialized international biopharmaceutical company transforming the lives of people with rare diseases. sobi is providing sustainable access to innovative therapies in the areas of haematology, immunology and specialty indications. today, sobi employs approximately 1,500 people across europe, north america, middle east, and asia. Share this article. stockholm, jan. 31, 2024 prnewswire sobi® will present new data at the 17th european association of haemophilia and allied disorders (eahad) conference in frankfurt from.
Sobi is a specialized international biopharmaceutical company transforming the lives of people with rare diseases. sobi is providing sustainable access to innovative therapies in the areas of haematology, immunology and specialty indications. today, sobi employs approximately 1,500 people across europe, north america, middle east, and asia. Share this article. stockholm, jan. 31, 2024 prnewswire sobi® will present new data at the 17th european association of haemophilia and allied disorders (eahad) conference in frankfurt from.
Comments are closed.